Clinical Trials
2 trialsNCT00354926 2016-01-07
Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma
Applied Molecular Evolution
Phase 1 Completed
NCT01858181 2014-03-03
Phase I Study of Subcutaneous Ocaratuzumab in Patients With Previously Treated CD20+ B-Cell Malignancies
Mentrik Biotech, LLC
Phase 1 Unknown